WallStSmart

Lineage, Inc. Common Stock (LINE)vsModiv Inc (MDV)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Lineage, Inc. Common Stock generates 11301% more annual revenue ($5.36B vs $47.01M). MDV leads profitability with a 0.3% profit margin vs -2.7%. LINE earns a higher WallStSmart Score of 34/100 (F).

LINE

Avoid

34

out of 100

Grade: F

Growth: 4.0Profit: 3.0Value: 5.0Quality: 3.0
Piotroski: 2/9Altman Z: 0.67

MDV

Avoid

32

out of 100

Grade: F

Growth: 2.7Profit: 5.5Value: 5.0Quality: 5.5
Piotroski: 4/9Altman Z: 0.21

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LINE1 strengths · Avg: 10.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

MDV2 strengths · Avg: 10.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

Operating MarginProfitability
40.9%10/10

Strong operational efficiency at 40.9%

Areas to Watch

LINE4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.4%4/10

0.4% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Operating MarginProfitability
3.3%3/10

Operating margin of 3.3%

Debt/EquityHealth
1.013/10

Elevated debt levels

MDV4 concerns · Avg: 3.0/10
Market CapQuality
$188.92M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.1%3/10

ROE of 0.1% — below average capital efficiency

Profit MarginProfitability
0.3%3/10

0.3% margin — thin

Debt/EquityHealth
1.763/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : LINE

The strongest argument for LINE centers on Price/Book.

Bull Case : MDV

The strongest argument for MDV centers on Price/Book, Operating Margin.

Bear Case : LINE

The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.

Bear Case : MDV

The primary concerns for MDV are Market Cap, Return on Equity, Profit Margin. Debt-to-equity of 1.76 is elevated, increasing financial risk. Thin 0.3% margins leave little buffer for downturns.

Key Dynamics to Monitor

LINE profiles as a turnaround stock while MDV is a value play — different risk/reward profiles.

LINE is growing revenue faster at 0.4% — sustainability is the question.

MDV generates stronger free cash flow (4M), providing more financial flexibility.

Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.

Bottom Line

LINE scores higher overall (34/100 vs 32/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Lineage, Inc. Common Stock

REAL ESTATE · REIT - INDUSTRIAL · USA

Lineage, Inc. (Ticker: LINE) is an innovative biotechnology company specializing in regenerative medicine, with a focus on developing state-of-the-art cell therapies for conditions such as ocular diseases, spinal cord injuries, and various cancers. Leveraging its proprietary technologies and strong strategic partnerships, Lineage aims to revolutionize patient care with pioneering therapeutic solutions. The company’s dedication to advancing its diverse product pipeline and accelerating clinical trials positions it as a compelling investment prospect for institutional investors looking to engage at the cutting edge of healthcare advancements.

Visit Website →

Modiv Inc

REAL ESTATE · REIT - INDUSTRIAL · USA

Modiv Inc (MDV) is a prominent real estate investment trust (REIT) specializing in the acquisition and management of single-tenant net lease properties across the United States, primarily investing in essential and financially robust businesses. The company leverages a disciplined investment strategy focused on long-term lease agreements, which enhances income stability and offers opportunities for capital appreciation. Modiv Inc is dedicated to sustainability and innovation, positioning itself uniquely within the real estate market while striving to provide attractive risk-adjusted returns for its investors.

Want to dig deeper into these stocks?